174 related articles for article (PubMed ID: 11587463)
21. Evaluation of antivenom therapy in Vipera palaestinae bites.
Bentur Y; Raikhlin-Eisenkraft B; Galperin M
Toxicon; 2004 Jul; 44(1):53-7. PubMed ID: 15225562
[TBL] [Abstract][Full Text] [Related]
22. European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.
Boels D; Hamel JF; Bretaudeau Deguigne M; Harry P
Clin Toxicol (Phila); 2012 Mar; 50(3):189-96. PubMed ID: 22372786
[TBL] [Abstract][Full Text] [Related]
23. Mechanism of Vipera berus venom activity and the principles of antivenom administration in treatment.
Czajka U; Wiatrzyk A; Lutyńska A
Przegl Epidemiol; 2013; 67(4):641-6, 729-33. PubMed ID: 24741911
[TBL] [Abstract][Full Text] [Related]
24. Incidence and characteristics of snakebite envenomations in the New York state between 2000 and 2010.
Joslin JD; Marraffa JM; Singh H; Mularella J
Wilderness Environ Med; 2014 Sep; 25(3):289-94. PubMed ID: 24841342
[TBL] [Abstract][Full Text] [Related]
25. A nationwide study of Vipera berus bites during one year-epidemiology and morbidity of 231 cases.
Karlson-Stiber C; Salmonson H; Persson H
Clin Toxicol (Phila); 2006; 44(1):25-30. PubMed ID: 16496490
[TBL] [Abstract][Full Text] [Related]
26. Vipera berus bites in Eastern Poland--a retrospective analysis of 15 case studies.
Garkowski A; Czupryna P; Zajkowska A; Pancewicz S; Moniuszko A; Kondrusik M; Grygorczuk S; Gołębicki P; Letmanowski M; Zajkowska J
Ann Agric Environ Med; 2012; 19(4):793-7. PubMed ID: 23289356
[TBL] [Abstract][Full Text] [Related]
27. Suspected Vipera palaestinae envenomation in three cats.
Michal MT; Eran L
Vet Hum Toxicol; 1999 Jun; 41(3):145-8. PubMed ID: 10349702
[TBL] [Abstract][Full Text] [Related]
28. Antivenom for European Vipera species envenoming.
Lamb T; de Haro L; Lonati D; Brvar M; Eddleston M
Clin Toxicol (Phila); 2017 Jul; 55(6):557-568. PubMed ID: 28349771
[TBL] [Abstract][Full Text] [Related]
29. Vipers of Major clinical relevance in Europe: Taxonomy, venom composition, toxicology and clinical management of human bites.
Di Nicola MR; Pontara A; Kass GEN; Kramer NI; Avella I; Pampena R; Mercuri SR; Dorne JLCM; Paolino G
Toxicology; 2021 Apr; 453():152724. PubMed ID: 33610611
[TBL] [Abstract][Full Text] [Related]
30. VENOMOUS SNAKEBITES IN CROATIA, CLINICAL PRESENTATION, DIAGNOSIS AND TREATMENT.
Tunjić Pejak D; Nesek Adam V; Srzić I
Acta Clin Croat; 2022 Jun; 61(Suppl 1):59-66. PubMed ID: 36304803
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for high-grade envenomations after French viper bites in children.
Claudet I; Maréchal C; Gurrera E; Cordier L; Honorat R; Grouteau E
Pediatr Emerg Care; 2012 Jul; 28(7):650-4. PubMed ID: 22743748
[TBL] [Abstract][Full Text] [Related]
32. Serum Cholesterol Concentration on Admission in 415 Dogs Envenomated by
Klainbart S; Kelmer E; Beeri-Cohen I; Keinan Y; Segev G; Aroch I
Toxins (Basel); 2023 Oct; 15(10):. PubMed ID: 37888640
[No Abstract] [Full Text] [Related]
33. Venomics of Vipera berus berus to explain differences in pathology elicited by Vipera ammodytes ammodytes envenomation: Therapeutic implications.
Latinović Z; Leonardi A; Šribar J; Sajevic T; Žužek MC; Frangež R; Halassy B; Trampuš-Bakija A; Pungerčar J; Križaj I
J Proteomics; 2016 Sep; 146():34-47. PubMed ID: 27327134
[TBL] [Abstract][Full Text] [Related]
34. Snakebites in Hungary--epidemiological and clinical aspects over the past 36 years.
Malina T; Krecsák L; Korsós Z; Takács Z
Toxicon; 2008 May; 51(6):943-51. PubMed ID: 18241904
[TBL] [Abstract][Full Text] [Related]
35. Use of antivenom in Vipera berus Bites--a comment.
Karlson-Stiber CB; Persson HE; Warrell DA
Wilderness Environ Med; 2010 Jun; 21(2):180; author reply 180-1. PubMed ID: 20591392
[No Abstract] [Full Text] [Related]
36. Case Report: Spherocytic Hemolytic Anemia after Envenomation by Long-Nosed Viper (
Liapis K; Charitaki E; Psaroulaki A
Am J Trop Med Hyg; 2019 Dec; 101(6):1442-1445. PubMed ID: 31674297
[TBL] [Abstract][Full Text] [Related]
37. [Snake bites in humans--observation recorded in Silesia region between 1999-2003].
Kepa L; Oczko-Grzesik B; Stolarz W
Przegl Epidemiol; 2004; 58(1):219-26. PubMed ID: 15218663
[TBL] [Abstract][Full Text] [Related]
38. Wilderness Medical Society Practice Guidelines for the Treatment of Pitviper Envenomations in the United States and Canada.
Kanaan NC; Ray J; Stewart M; Russell KW; Fuller M; Bush SP; Caravati EM; Cardwell MD; Norris RL; Weinstein SA
Wilderness Environ Med; 2015 Dec; 26(4):472-87. PubMed ID: 26433731
[No Abstract] [Full Text] [Related]
39. [Updated guidelines for the treatment of viper bites].
Personne M; Hultén P; Arvidsson S
Lakartidningen; 2017 Jun; 114():. PubMed ID: 28608909
[No Abstract] [Full Text] [Related]
40. Daboia (Vipera) palaestinae envenomation in horses: Clinical and hematological signs, risk factors for mortality and construction of a novel severity scoring system.
Tirosh-Levy S; Solomovich R; Comte J; Sutton GA; Steinman A
Toxicon; 2017 Oct; 137():58-64. PubMed ID: 28698056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
